Radiofrequency Ablation Versus Partial Hepatectomy For Recurrent Hepatocellular Carcinoma After Liver Transplantation | 3510
Journal of Gastrointestinal & Digestive System
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Radiofrequency ablation (RFA) is a widely used, effective, and reliable therapy for HCC; however, whether RFA is as
effective as surgical resection for recurrent HCC after liver transplantation (LT) remains unknown.
394 consecutive HCC patients were given LT from February 1996 to February 2009 in our centre, 202 had recurrence, of
which 58 patients with localized intrahepatic recurrence who were treated by either surgical resection or RFA included. Patients were
followed-up regularly after treatment until death or the end of the study period.
The 5-year overall survival rate after treatment was 14.5% for the surgical resection group and 16.7% for the RFA group. No
significant difference was found in overall survival from the date of treatment (p=0.518). The 5-year overall survival rate from the date
of liver transplantation was 22.4% for the surgical resection group and 20.1% for the RFA group. Difference was not significant in overall
survival from the date of liver transplantation (p=0.726). The 5-year re-recurrence-free survival rate was 10.0% for the surgical resection
group and 9.5% for the RFA group. There was no significant difference in re-recurrence-free survival as well (p=0.448). Interval of
recurrence from LT ≤1year had a relative risk of 11.932 (95% CI=4.145-23.327) and microvascular invasion had a relative risk of 22.751
(95% CI=8.542-32.155) for overall survival.
RFA for isolated intrahepatic recurrent HCC after LT has similar long-term survival as surgical resection, but RFA is less invasiv
Jiwei Huang has completed his Ph.D. and M.D. at the age of 33 years from West China Medical School of Sichuan University and works in
the Department of Hepatobiliary Pancreatic Surgery, West China Hospital, Sichuan University. He is an outstanding young surgeon and clinical
researcher who has received many awards. He is in charge of several major registered clinical trials. He has published more than 30 papers in
reputed journals (including ?Annals of Surgery?) and books.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals